| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Medical Officer | Chief Medical Officer
1 company
Inrig Jula is a Chief Medical Officer at TVTX. Recent filings cover 0 purchases and 19 sales. Those positions are worth an estimated $6.7M at current prices.
Our model assigns Inrig Jula a below-average insider score of 44/100, based on 19 past trades. Over a 12-month horizon, 15.4% of those trades were profitable, with an average 12-month return of -60.7%.
Inrig Jula's largest disclosed position is in TVTX as Chief Medical Officer, worth about $6.7M. The recent filings there lean toward selling, a net 53,878 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb 1, 2024 | TVTX Travere Therapeutics, Inc. | Chief Medical Officer | Sell | 2,174 | $8.53 | $18,546.61 | -3.6% | -30.2% | +137.9% | |
| Jan 4, 2024 | TVTX Travere Therapeutics, Inc. | Chief Medical Officer | Sell | 2,509 | $9.43 | $23,647.68 | -3.4% | -23.2% | +107.5% | |
| Jan 5, 2023 | TVTX Travere Therapeutics, Inc. | Chief Medical Officer | Sell | 2,493 | $20.75 | $51,729.75 | -6.6% | +1.6% | -57.9% |